Mahady M Joseph

CIK 1187302 · Sr. VP & Pres., Wyeth Pharma. · last filed 2021-02-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$647.4K

Companies

4

Total Filings

27

Lifetime Open-Market Net

$15.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
WINT Director 7,455 $0.01 $107 $15.0K 7 2021-02-05
DSCO Director 26,079 $24.82 $647.3K $0 3 2015-08-18
ALB Director $170.42 $0 9 2014-07-03
WYETH (WYEp) Delisted Sr. VP & Pres., Wyeth Pharma. 91,154 $0 6 2009-03-03

Recent Filings · Page 3 of 3

27 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2009-10-19 Disp (D) −274,214 $0
2009-03-03 WYETH (WYEp) Delisted Mixed +30,706 -$862.9K EDGAR
2008-04-28 WYETH (WYEp) Delisted Grant (A) $0 EDGAR
2008-03-04 WYETH (WYEp) Delisted Mixed +26,371 -$766.3K EDGAR
2007-04-30 WYETH (WYEp) Delisted Grant (A) $0 EDGAR
2007-02-28 WYETH (WYEp) Delisted Mixed +83,047 -$109.0K EDGAR
2007-01-29 WYETH (WYEp) Delisted Mixed +1,243 -$1.4K EDGAR
Showing 2127 of 27
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.